In 2024, JD Health International completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
JD Health International has also provided a category-level breakdown for 5 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021-2019 |
|---|---|---|---|---|
Total Scope 1 | 68.13a | 174.66a | 75.42b | |
Total Scope 2 | ||||
Unspecified Calculation Method | 3,768.75a | 5,089.05a | 1,868.61b | |
Total Scope 3 | 204,951.84a | 134,699.93a | 53,483.52b | |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 0.0085a | 0.0232a | 0.0112b |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2024, the total operational greenhouse gas (GHG) emissions of JD Health International amounted to 3,836.88 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of JD Health International decreased by 27.11%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a
In 2024, the total Scope 1 emissions of JD Health International were 68.13 metric tons of CO₂ equivalent (tCO₂e).a
Since 2021, JD Health International's Scope 1 emissions have increased by 102.11%, reflecting a rising long-term trend in Scope 1 emissions over time.ac
Compared to the previous year (2023), JD Health International's Scope 1 emissions decreased by 60.99%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a
In 2024, JD Health International reported Scope 2 greenhouse gas (GHG) emissions of 3,768.75 tCO₂e without specifying the calculation method.a
Since 2021, JD Health International's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have increased by 645.08%, reflecting a rising long-term trend in Scope 2 emissions over time.ac
Compared to the previous year (2023), JD Health International's Scope 2 emissions (Unspecified Calculation Method) fell by 25.94% in 2024, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.a
In 2024, JD Health International reported its Scope 2 emissions using an unspecified methodology.a
In 2024, JD Health International reported 204,951.84 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2024 disclosure of JD Health International includes a breakdown across 5 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
In 2024, JD Health International reported total Scope 3 emissions of 204,951.84 metric tons of CO₂ equivalent (tCO₂e).a
Approximately 100% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0% came from downstream activities like product use, distribution, and end-of-life treatment.a
Compared to the previous year (2023), JD Health International's Scope 3 emissions increased by 52.15%, suggesting that the company faced challenges in reducing emissions across its value chain.a
In 2024, JD Health International reported emissions for 5 out of the 15 Scope 3 categories defined by the GHG Protocol.a
This partial disclosure allows for some insight into the company's indirect impacts.
In 2024, the largest contributors to JD Health International's Scope 3 emissions were:a
In 2024, JD Health International reported Scope 1 greenhouse gas (GHG) emissions of 68.13 tCO₂e and total revenues of USD 8,015 millions. This translates into an emissions intensity of 0.01 tCO₂e per millions USD.a
In 2024, JD Health International reported a Scope 1 emissions intensity of 0.01 tCO₂e per millions USD. Compared to the peer group median of 1.44, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a
In 2024, JD Health International ranked 2 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
This places JD Health International among the top performers, with one of the lowest emissions intensities relative to peers.a
In 2024, JD Health International reported a total carbon footprint of 208,788.72 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 49.17% increase compared to 2023, suggesting a rise in emissions across its operations or value chain.a
The largest contributor to JD Health International's total carbon footprint was Scope 3 emissions, accounting for 98.16% of the company's total carbon footprint, followed by Scope 2 emissions at 1.81%.a